Applied Research Investments’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$212K Sell
418
-1,258
-75% -$704K 4.28% 12
2022
Q2
$911K Sell
1,676
-530
-24% -$292K 4.03% 7
2022
Q1
$1.3M Sell
2,206
-8,823
-80% -$5.07M 3.89% 8
2021
Q4
$7.36M Buy
11,029
+812
+8% +$507K 2.43% 15
2021
Q3
$5.84M Sell
10,217
-417
-4% -$229K 1.94% 19
2021
Q2
$5.37M Sell
10,634
-1,935
-15% -$913K 1.92% 17
2021
Q1
$5.74M Buy
12,569
+601
+5% +$287K 2.09% 14
2020
Q4
$5.57M Buy
11,968
+2,181
+22% +$1.02M 2.37% 12
2020
Q3
$4.32M Buy
9,787
+1,915
+24% +$791K 2.44% 10
2020
Q2
$2.85M Buy
+7,872
New +$2.64M 2.49% 13

Other funds holding TMO

Applied Research Investments's TMO Position: Q3 2022 in Review

Applied Research Investments reduced its Thermo Fisher Scientific (TMO) stake by 75% in Q3 2022, selling an estimated $704K and leaving 418 shares worth $212K. The position accounts for 4.28% of the portfolio, ranked #12.

Applied Research Investments first reported a position in TMO in Q2 2020 and has held it in 10 quarters since. The position peaked at $7.36M in Q4 2021. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • Applied Research Investments held 418 shares of Thermo Fisher Scientific worth $212K as of Q3 2022.
  • Applied Research Investments sold 1,258 Thermo Fisher Scientific shares in Q3 2022, an estimated $704K.
  • Thermo Fisher Scientific made up 4.28% of Applied Research Investments's portfolio in Q3 2022, its #12 holding.
  • Applied Research Investments first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 10 quarters since.
  • Applied Research Investments's Thermo Fisher Scientific position peaked at $7.36M in Q4 2021.
  • 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Applied Research Investments's 13F filing for Q3 2022, filed 14 Nov 2022.